EAS Health

EAS Health We are an insurtech startup aiming at building a global mutual aid platform based on blockchain and

It has been reported that the bar for the VATP License is quite high. The key requirements include but not limited to th...
07/05/2020

It has been reported that the bar for the VATP License is quite high. The key requirements include but not limited to the following – arrangement of custody of assets through a trust structure holding a TCSP License, full insurance coverage for the client virtual assets, a quality team of management and operation, trade surveillance of virtual assets transactions for maintaining a fair market, and high-quality technical trading platform product. Congratulations to the team.

GlobalSTOX Limited (“GSL”) is pleased to announce that its wholly-owned subsidiary, HKSTOX Finance Limited, has successfully obtained a Trust or Company Service Provider License (“TCSP License”) on

The Chinese central government has put together a national blockchain committee to work on setting industrial standards....
15/04/2020

The Chinese central government has put together a national blockchain committee to work on setting industrial standards. The committee would be made up of 71 individuals from different backgrounds, including political, industrial, academic, and research organizations.

The Chinese central government has put together a national blockchain committee to work on setting industrial standards. The Ministry of Industry and Information Technology (MIIT) issued a notice o

Join our telegram group: https://t.me/eashealthChinese users, just scan below QR code directly to receive EAS red packet...
15/04/2020

Join our telegram group: https://t.me/eashealth

Chinese users, just scan below QR code directly to receive EAS red packets.

April 10, 2020, Gilead Sciences, Inc. (Nasdaq: GILD) announced results from a cohort analysis of 53 patients hospitalize...
11/04/2020

April 10, 2020, Gilead Sciences, Inc. (Nasdaq: GILD) announced results from a cohort analysis of 53 patients hospitalized with severe complications of COVID-19 who were treated with the investigational antiviral remdesivir on an individual compassionate use basis. The majority of patients in this international cohort demonstrated clinical improvement and no new safety signals were identified with remdesivir treatment.

Data on 53 Patients Treated With Investigational Antiviral Remdesivir Through the Compassionate Use Program Published in New England Journal of Medicine

From Blockchain.News: The price of Bitcoin has seen a decline of 8 percent from the start of this year until early April...
09/04/2020

From Blockchain.News: The price of Bitcoin has seen a decline of 8 percent from the start of this year until early April, and 90% of Finder's survey panel believes it is caused by the coronavirus pandemic; however, it's not the only reason. Read the article to find out more.

The price of Bitcoin has seen a decline of 8 percent from the start of this year until early April, and 90% of Finder’s survey panel believe is caused by the coronavirus pandemic. Although COVID-19

Chloroquine is a medication primarily used to prevent and treat malaria in areas where malaria remains sensitive to its ...
09/04/2020

Chloroquine is a medication primarily used to prevent and treat malaria in areas where malaria remains sensitive to its effects. Trade names‎: ‎Aralen. Find out more.

Chloroquine stands out as a potentially simple, cheap, and scalable COVID-19 treatment, though we haven't seen data from randomized clinical trials.

Address

Hong Kong

Alerts

Be the first to know and let us send you an email when EAS Health posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to EAS Health:

Share